Venezuela Circular DGSACS-008/2026: Import Requirements and Label Authorization

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Circular N° DGSACS-008/2026, published on July 9, 2026 and signed by the SACS Director General Dra. Esperanza Briceño Godoy, is the most consequential Venezuelan import control circular of 2026. It sets out three core requirements: (1) goods under legal regime 3 and legal regime 12, together with all consumer products for human use, must strictly comply with the sanitary regulations in force; (2) importers must submit a valid sanitary registration, import permit and listings; (3) destination labelling must be formally authorized.

The conclusion is this: the circular elevates label authorization from a marketing requirement to a customs clearance condition. Previously a labelling problem was typically identified during market surveillance; it is now intercepted at the customs stage. For supply chains that depend on applying Spanish-language labels after the goods arrive, this is a process-level change and not a documentation adjustment, because the physical work sequence itself becomes impermissible.

The commercial effect is easy to understate. A shipment held at the border for a labelling reason does not merely incur storage cost; it also consumes the importer’s working capital, delays the distributor’s commitments to hospitals, and in tenders with fixed delivery windows can cost the contract outright. The compliance cost of pre-authorized labelling is measurable in advance, while the cost of a blocked consignment is not.

2. Legal basis

InstrumentNumberPublication dateProvisions
Circular N° DGSACS-008/2026DGSACS-008/2026July 9, 2026Sanitary import requirements for goods under legal regime 3 (sanitary import permit) and legal regime 12 (sanitary registration); destination labelling requires authorization
Circular N° DGSACS/0002/2025DGSACS/0002/2025October 28, 2025Predecessor circular: platform mandate and renaming of legal regime 12
Decreto N° 5.165Decreto N° 5.165September 30, 2025Handling authority for legal regimes 3, 8 and 12
Decreto N° 4.944 (tariff schedule)G.O. N° 6.804 ExtraordinarioApril 25, 2024Article 37: tariff basis of the legal regimes

The instruments in the table form a chain rather than a set. The tariff schedule attaches legal regimes to ten-digit codes, Decreto N° 5.165 assigns their handling to the foreign trade commission, the 2025 circular moves the procedure onto the platform and renames regime 12, and the 2026 circular states what has to be presented and what has to be authorized before goods may enter. Reading the chain in order shows why the three requirements are cumulative: each one corresponds to a different layer of the same control.

3. Expert insights

1. The three requirements are parallel, not alternative. The circular uses the formulation requiring valid sanitary registrations, import permits and listings (registros sanitarios, permisos de importación y listados vigentes), placing the three side by side. Holding a certificate without an import permit, or holding a permit with an unauthorized label, satisfies none of them. This is fully consistent with the analysis in article 07 of this series on the two legal regimes operating in parallel: a product can be correctly registered and still not legally importable.

2. The listings item is the one most easily overlooked. Beyond registration and permit, the circular also requires listings to be submitted. This indicates that the authority expects a checkable itemization of the products, not merely an approval document. In practice the file should contain a listing that maps one to one against the consignment, including product name, model, batch and quantity. A listing that describes the portfolio rather than the shipment does not perform the function the circular assigns to it.

Label authorization deserves the same precision. Authorization attaches to a specific label content, a specific product and, in practice, a specific destination. It is not a general permission to sell the product under any presentation, so a change of artwork, of language layout or of the information block can remove the shipment from the scope of what was authorized even where the registration remains valid. Keeping a dated copy of the authorized artwork and comparing it against the production label before dispatch is the control that closes this gap.

3. The circular commits to responding within an established period and before the goods arrive. That wording carries two meanings: SACS acknowledges that a fixed period exists, and the application is to be submitted before arrival. For companies this is an actionable optimization point, since early filing avoids the waiting time and port storage cost that follow arrival (article 37 of this series). The commitment is also worth documenting, because a dated submission establishes the reference point against which the response period can be measured.

4. It forms a continuous tightening sequence with the 2025 circular. Circular DGSACS/0002/2025 resolved the entry side, unifying the platform and the terminology, while Circular DGSACS-008/2026 resolves the exit side, setting the enforcement standard at customs. Tightening at both ends indicates that this round of reform is systemic rather than a set of isolated adjustments. Companies should plan on the assumption that the next instrument in the sequence will address the remaining gap, most plausibly the data standards used across the three systems.

4. Practical recommendations

  1. Importers: expand the pre-shipment check to four items, namely a valid sanitary registration certificate, a valid import permit, a complete listing that matches the actual goods, and an authorized destination label.
  2. Supply chain teams: complete label authorization before shipment and abandon the practice of labelling on arrival.
  3. Regulatory affairs leads: file sanitary permit and label authorization applications before the goods arrive, using the response mechanism the circular commits to.
  4. Importers: build a listing template that preserves a verifiable correspondence between the physical goods, the invoice and the bill of lading.
  5. Regulatory affairs leads: add this circular to the SACS monitoring list and track whether implementing rules or a replacement version follow.

5. Verification checklist

  • □ The four pre-shipment checks (certificate, permit, listing, label authorization) are built into the operating checklist
  • □ Label authorization is completed before shipment
  • □ Sanitary permit and label authorization applications are submitted before the goods arrive
  • □ A listing template exists and matches the goods, invoice and bill of lading
  • □ The circular is on the monitoring list with a defined review frequency

Regulatory information verified as of October 29, 2026

All conclusions published here defer to the current regulatory texts as issued by the competent authority, verified item by item before delivery.

— GRZAN Regulatory Team

GRZAN supports medical device and IVD manufacturers, importers and authorized representatives with registration and post-market compliance in Venezuela: dossier preparation and filing through the SACS and COMEX channels, license-holder coordination, technovigilance and adverse event workflows, recall and field corrective action planning, inspection readiness, and continuous monitoring of circulares and decrees. For tailored support on your Venezuela portfolio, contact the GRZAN regulatory team at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail